Liz Highleyman
Published: 24 May 2017
A community-led buyers club in Indonesia has helped more than 100 people get generic direct-acting antiviral (DAA) drugs to treat hepatitis C and is seeing a high cure rate, according to a presentation at the 25th International Harm Reduction Conference (HR17) last week in Montréal.
An estimated 3 million people in Indonesia are living with hepatitis C virus (HCV), according to Sindi Putri of the Indonesia AIDS Coalition (IAC). The number of people who inject drugs is estimated at nearly 106,000, of whom 77% are thought to have hepatitis C. Co-infection with HIV and HCV is common in this population.
Continue Reading
NAM aidsmap
Conference news: HR17
An estimated 3 million people in Indonesia are living with hepatitis C virus (HCV), according to Sindi Putri of the Indonesia AIDS Coalition (IAC). The number of people who inject drugs is estimated at nearly 106,000, of whom 77% are thought to have hepatitis C. Co-infection with HIV and HCV is common in this population.
Continue Reading
NAM aidsmap
Conference news: HR17
The 25th International Harm Reduction Conference (HR17) was held in Montréal, Canada from 14-17 May.
Related Articles On This Blog
HCV genericsRelated Articles On This Blog
No comments:
Post a Comment